DE69024965D1 - Dehydrodidemnin b - Google Patents

Dehydrodidemnin b

Info

Publication number
DE69024965D1
DE69024965D1 DE69024965T DE69024965T DE69024965D1 DE 69024965 D1 DE69024965 D1 DE 69024965D1 DE 69024965 T DE69024965 T DE 69024965T DE 69024965 T DE69024965 T DE 69024965T DE 69024965 D1 DE69024965 D1 DE 69024965D1
Authority
DE
Germany
Prior art keywords
dehydrodidemnin
synthesized
isolated
formula
biological activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69024965T
Other languages
English (en)
Other versions
DE69024965T2 (de
Inventor
Kenneth Rinehart
A Lithgow-Bertelloni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Application granted granted Critical
Publication of DE69024965D1 publication Critical patent/DE69024965D1/de
Publication of DE69024965T2 publication Critical patent/DE69024965T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855Proteins from animals other than mammals or birds
    • Y10S530/857Fish; fish eggs; shell fish; crustacea
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69024965T 1989-09-29 1990-10-01 Dehydrodidemnin b Expired - Lifetime DE69024965T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898922026A GB8922026D0 (en) 1989-09-29 1989-09-29 Novel anti-viral and cytotoxic agent
PCT/GB1990/001495 WO1991004985A1 (en) 1989-09-29 1990-10-01 Dehydrodidemnin b

Publications (2)

Publication Number Publication Date
DE69024965D1 true DE69024965D1 (de) 1996-02-29
DE69024965T2 DE69024965T2 (de) 1996-08-22

Family

ID=10663828

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69024965T Expired - Lifetime DE69024965T2 (de) 1989-09-29 1990-10-01 Dehydrodidemnin b

Country Status (10)

Country Link
US (4) US5834586A (de)
EP (1) EP0493480B1 (de)
JP (1) JP2919965B2 (de)
AT (1) ATE133181T1 (de)
AU (1) AU642169B2 (de)
DE (1) DE69024965T2 (de)
DK (1) DK0493480T3 (de)
ES (1) ES2082003T3 (de)
GB (1) GB8922026D0 (de)
WO (1) WO1991004985A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
GB8922026D0 (en) 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
ES2102322B1 (es) * 1995-07-13 1998-03-01 Pharma Mar Sa Procedimiento de preparacion de didemnina a.
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US6218424B1 (en) 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
US6034058A (en) * 1997-04-15 2000-03-07 Rinehart; Kenneth L. Semi-synthetic alanyl dilemnin analogs
EP0981352B8 (de) * 1997-05-07 2009-06-17 Pharma Mar, S.A. Verwendung von Aplidine zur Behandlung von kardiovaskulären Erkrankungen
US6271244B1 (en) 1998-06-03 2001-08-07 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
US6274602B1 (en) 1998-06-03 2001-08-14 Gpi Nil Holdings, Inc. Heterocyclic thioester and ketone hair growth compositions and uses
US6187784B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6187796B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Sulfone hair growth compositions and uses
AT405400B (de) * 1997-11-12 1999-07-26 Chemie Linz Gmbh Verfahren zur herstellung von 1-pyruvyl-l-prolin
AT405399B (de) * 1997-08-06 1999-07-26 Chemie Linz Gmbh Verfahren zur herstellung von 1-pyruvoyl-l-prolin
CZ291417B6 (cs) * 1997-08-06 2003-03-12 Dsm Fine Chemicals Austria Nfg Gmbh & Co Kg Způsob výroby 1-pyruvyl-L-prolinu
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
US6429215B1 (en) 1998-06-03 2002-08-06 Gpi Nil Holdings, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
WO1999062487A1 (en) 1998-06-03 1999-12-09 Gpi Nil Holdings, Inc. Heterocyclic ester and amide hair growth compositions and uses
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
US6172087B1 (en) 1998-06-03 2001-01-09 Gpi Nil Holding, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6333340B1 (en) 1998-08-14 2001-12-25 Gpi Nil Holdings, Inc. Small molecule sulfonamides for vision and memory disorders
US6399648B1 (en) 1998-08-14 2002-06-04 Gpi Nil Holdings, Inc. N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
US6506788B1 (en) 1998-08-14 2003-01-14 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
US6376517B1 (en) 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
US6384056B1 (en) 1998-08-14 2002-05-07 Gpi Nil Holdings, Inc. Heterocyclic thioesters or ketones for vision and memory disorders
US6335348B1 (en) 1998-08-14 2002-01-01 Gpi Nil Holdings, Inc. Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders
US6337340B1 (en) 1998-08-14 2002-01-08 Gpi Nil Holdings, Inc. Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
US6395758B1 (en) 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6339101B1 (en) 1998-08-14 2002-01-15 Gpi Nil Holdings, Inc. N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
BR0015811A (pt) * 1999-11-15 2002-08-06 Pharma Mar Sa Tratamento de c nceres com aplidina
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
ES2243555T3 (es) 2000-10-12 2005-12-01 Pharma Mar, S.A. Tratamiento de canceres mediante aplidina en conjuncion con carnitina o acetilcarnitina.
CA2424823A1 (en) * 2000-10-12 2002-04-18 Pharma Mar, S.A. Treatment of cancers by aplidine in conjunction with a myoprotector
ES2315404T3 (es) * 2001-10-19 2009-04-01 Pharma Mar, S.A. Uso de aplidina para el tratamiento de cancer de pancreas.
ES2312979T3 (es) 2003-03-12 2009-03-01 Dana-Farber Cancer Institute, Inc. Aplidina para el tratamiento de mieloma multiple.
CA2516572A1 (en) * 2003-03-12 2004-09-23 Pharma Mar, S.A. Improved antitumoral treatments
EP1942944A2 (de) * 2005-10-31 2008-07-16 Genentech, Inc. Makrozyklische depsipeptid-antikörper-wirkstoff-konjugate und entsprechende verfahren
AU2007220050B2 (en) 2006-02-28 2013-08-29 Pharma Mar, S.A. Improved antitumoral treatments
WO2008080956A1 (en) * 2006-12-29 2008-07-10 Pharma Mar, S.A. Prognostic molecular markers for the cancer therapy with aplidine
WO2009050296A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
CN101965191A (zh) * 2008-03-07 2011-02-02 法马马有限公司 改善的抗癌治疗
US9644005B2 (en) 2011-09-21 2017-05-09 King Abdullah University Of Science And Technology Didemnin biosynthetic gene cluster in Tistrella mobilis
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
KR20220150348A (ko) * 2020-03-02 2022-11-10 파르마 마르, 에스.에이. 코로나바이러스의 치료에 조합하여 사용하기 위한 pld
US20230158102A1 (en) * 2020-03-02 2023-05-25 Pharma Mar, S.A. Compounds for use in the treatment of coronavirus infection
US20230158104A1 (en) * 2020-03-02 2023-05-25 Pharma Mar, S.A. Compounds for use in autoimmune conditions
TW202144381A (zh) * 2020-03-02 2021-12-01 西班牙商瑪製藥股份有限公司 用於炎症之化合物
CN115594739A (zh) * 2021-06-28 2023-01-13 浙江珲达生物科技有限公司(Cn) 一种dehydrodidemnin B类化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4493796A (en) * 1980-09-12 1985-01-15 Board Of Trustees, Univ. Of Ill. Didemnins A, B, C, and derivatives thereof, as antiviral agents
US4950649A (en) 1980-09-12 1990-08-21 University Of Illinois Didemnins and nordidemnins
GB8922026D0 (en) 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
TW222637B (de) * 1991-12-12 1994-04-21 Hoechst Ag
US6034058A (en) 1997-04-15 2000-03-07 Rinehart; Kenneth L. Semi-synthetic alanyl dilemnin analogs
EP0981352B8 (de) 1997-05-07 2009-06-17 Pharma Mar, S.A. Verwendung von Aplidine zur Behandlung von kardiovaskulären Erkrankungen

Also Published As

Publication number Publication date
US6710029B1 (en) 2004-03-23
DE69024965T2 (de) 1996-08-22
GB8922026D0 (en) 1989-11-15
JP2919965B2 (ja) 1999-07-19
AU642169B2 (en) 1993-10-14
WO1991004985A1 (en) 1991-04-18
US5834586A (en) 1998-11-10
USRE39887E1 (en) 2007-10-16
DK0493480T3 (da) 1996-05-20
JPH05502441A (ja) 1993-04-28
ATE133181T1 (de) 1996-02-15
ES2082003T3 (es) 1996-03-16
US6153731A (en) 2000-11-28
EP0493480A1 (de) 1992-07-08
EP0493480B1 (de) 1996-01-17
AU6441290A (en) 1991-04-28

Similar Documents

Publication Publication Date Title
ATE133181T1 (de) Dehydrodidemnin b
MY104685A (en) Substituted thiazoles and their use as fungicides.
DK0608912T3 (da) Synergistiske mikrobicide sammensætninger
DE3884791D1 (de) Begasungs-Brutschrank.
NO930615L (no) Hypoglykemiske hydroksyurinstoffderivater
ES2054778T3 (es) Complejos de 1,2-bis (aminometil) ciclobutano-platino.
ATE265997T1 (de) Substituierte tetrahydronaphthalin- und dihydronaphthalin-derivate mit einer retinoiden und/oder retinoid antagonist-ähnlichen biologischen aktivität
DE3867659D1 (de) 1,5-diphenyl-1h-1,2,4-triazol-3-carboxamid-derivate und diese enthaltende herbizide zusammensetzungen.
ES2099274T3 (es) Derivados de estreptolisina o.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
DE69016693D1 (de) Züchtung von transformierten Mikroorganismen.
ES2098263T3 (es) 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos.
FI964448A0 (fi) Uusi biologisesti aktiivinen peptidi ja sen valmistus
ATE174911T1 (de) 1-dimethylcarbamoyl-1h-1,2,4-triazole- substituiert in stellungen 3 und 5
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
ES2181722T3 (es) Marcfortinas sustituidas en la posicion 14 y derivados utiles como agentes antiparasitarios.
DE3878988D1 (de) 1,2-di(4-isobutylphenyl)aethylen, dessen herstellung und verwendung als zwischenprodukt.
ES2052499T3 (es) Complejos de (gem-heterociclodimenatamina-n,n') platino.
ES2086449T3 (es) 2-terbutil-4-cloro-5-(4-ibutilmetilciclohexil)-metiltio-3(h)-piridazinona con actividad acaricida e insecticida.
MX9800306A (es) Mezclas fungicidas.
ITFE930013U1 (it) Bacchette orientali meccanizzate.
MY128749A (en) Fungicidal mixtures
TH5761B (th) วิธีการเตรียมชิ้นกล้าสำหรับการเลี้ยงเนื้อเยื่อพืช

Legal Events

Date Code Title Description
8364 No opposition during term of opposition